Nine years ago, the spark of Youth Day illuminated our first line of code.

We declared to the world—China would build its own surgical robot.

Back then, we could only look up at the giants.

Today, amid the gong of the Hong Kong Stock Exchange, Edge^® has completed over 10,000 procedures of more than 200 hospitals worldwide. The code and blueprints from our laboratory have grown into tangible life-saving impact.

From technological breakthroughs to product innovation, from clinical adoption to industry transformation, from rooting in China to expanding globally—these nine years represent not only Edge^®'s journey of growth and transformation, but also the story of China's surgical robotics industry emerging onto the world stage.

Chapter One

A New Technical Benchmark

Technological barriers are walls built by time. The longer the wait, the thicker the wall becomes.

We remain committed to full-stack self-development, dedicated to overcoming the core technological barriers in surgical robotics.

Today, Edge^® has established a comprehensive product matrix encompassing multi-port, single-port, and tele-surgery systems, extending into specialized domains such as bronchoscopy robotics—pioneering as a platform-level integration leader in the global surgical robotics field.

With groundbreaking innovations including the world's first "single-multi-port integrated" super system and the first-ever "three-in-one" surgical robotic platform, we have redefined a new paradigm for "comprehensive minimally invasive" care.

We have guided tele-surgery from technical exploration into large-scale clinical adoption, initiating a global dialogue on healthcare resource distribution.

Domestically, through the "Thousand-Hospital Alliance" initiative, we enable one-click connectivity between tertiary hospitals and community hospitals, allowing quality medical resources to transcend geographical boundaries.

Overseas, we have helped multiple countries achieve their first successful tele-surgery procedures, using stunning live demonstrations to guide Chinese surgical robotics from "participant" to "defining innovator" on the world stage.

Chapter Two

A New Market Landscape

Surgical robotics is no longer a "luxury" reserved for top-tier hospitals.

While continuing to expand our presence in China's leading hospital networks, we have also completed commercial installations in county-level community hospitals across multiple provinces, achieving full coverage across provincial, municipal, and county-level hospital networks—breaking the traditional perception that "advanced equipment is only accessible to large hospitals," and truly making domestic high-end medical technology an "accelerator" for accessible healthcare.

Edge^® multi-port surgical robotics has achieved the highest annual sales volume among domestic brands in China.

Overseas, with our distinctive "China Solution", we have successfully established a clear identity as "Global Surgical Robotics Innovator," becoming a new calling card for China's high-end medical equipment on the world stage.

We have systematically woven a commercial network covering key markets worldwide, enabling "Made in China" intelligence to take root across diverse regions.

From market access to commercial implementation, from technology leadership to brand recognition—Edge^® products now reach more than 20 countries and regions globally.

We are advancing toward large-scale development with steady strides, affirming the strategic conviction that "only innovation leads industry trends, and only determined global expansion integrates with the pulse of the world."

"Made in China" is becoming the most confident choice in operating rooms worldwide.

Chapter Three

A New Height of Value

From a single office in an incubation hub to the center of the world's capital stage—on January 8, 2026, Edge Medical debuted on the Hong Kong Stock Exchange.

Nine years represents a story of how "trust" is validated over time: China's "Made in China" surgical robotics goes beyond mere "replacement"—it can stand on the world's main stage through technology, quality, and systematic global deployment capabilities.

As we mark our ninth anniversary, we present our first "report card" following listing:

- Annual revenue: 456 million RMB, representing 185% year-over-year growth

- Gross profit: 301 million RMB, representing 207% year-over-year growth

- Gross margin: 66%, exceeding 58% for three consecutive years.

- We became the second company globally to achieve "half-year profitability" in surgical robotics

Every number is a response to trust.

This is Edge^®'s coming-of-age ceremony, and our most solemn answer to the word "longevity."

At eight years, we spoke of "journeying toward infinity."

At nine years, we share this: the true essence of infinity is not endless wandering—it is the quiet strength of what endures.

Boundless exploration is composed of countless moments of enduring commitment.

Nine years of deep roots is the complete foundation and honor behind our promise of "lasting dedication."

Standing at the new starting point of our listing year, our original vision remains unchanged.

We believe technology can transform the world, and that the mission to "To advance surgical technology, empower surgeons and benefit patients" is worth a lifetime of pursuit.

This is a new journey dedicated to the broader well-being of patients and the medical community worldwide.